{"id":9,"date":"2012-06-11T14:02:18","date_gmt":"2012-06-11T12:02:18","guid":{"rendered":"http:\/\/semmelweis-egyetem.hu\/gyogyszertar\/?page_id=9"},"modified":"2025-02-17T10:26:54","modified_gmt":"2025-02-17T09:26:54","slug":"kutatas-fejlesztes","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/gyogyszertar\/kutatas-fejlesztes\/","title":{"rendered":"Int\u00e9zet\u00fcnk kutat\u00e1si tev\u00e9kenys\u00e9ge"},"content":{"rendered":"<p>Int\u00e9zet\u00fcnk n\u00e9gy kutat\u00f3csoportban v\u00e9gzi tev\u00e9kenys\u00e9g\u00e9t, amelyek a gy\u00f3gyszertechnol\u00f3gia, a betegell\u00e1t\u00e1s, az eg\u00e9szs\u00e9gtudom\u00e1ny \u00e9s a nanotechnol\u00f3gia ter\u00fclet\u00e9re \u00f6sszpontos\u00edtanak. A kutat\u00e1sok c\u00e9lja a modern gy\u00f3gyszer\u00e9szet fejl\u0151d\u00e9s\u00e9nek el\u0151seg\u00edt\u00e9se, a betegek ter\u00e1pi\u00e1s lehet\u0151s\u00e9geinek jav\u00edt\u00e1sa, valamint betegk\u00f6zpont\u00fa, innovat\u00edv gy\u00f3gyszerform\u00e1k fejleszt\u00e9se.<\/p>\n<ol style=\"list-style-type: upper-roman\">\n<li><strong>Gy\u00f3gyszer\u00e9szi gondoz\u00e1s, klinikai gy\u00f3gyszer\u00e9szet kutat\u00f3csoport<\/strong><br \/>\nA csoport f\u0151 kutat\u00e1si ter\u00fcletei k\u00f6z\u00e9 tartozik a kr\u00f3nikus betegek gy\u00f3gyszeres ter\u00e1pi\u00e1j\u00e1nak elemz\u00e9se, a gy\u00f3gyszerel\u00e9si probl\u00e9m\u00e1k felismer\u00e9se \u00e9s megel\u0151z\u00e9se, valamint a beteg ter\u00e1pi\u00e1s egy\u00fcttm\u0171k\u00f6d\u00e9s\u00e9nek n\u00f6vel\u00e9se. Vizsg\u00e1lj\u00e1k a bizony\u00edt\u00e9kokon alapul\u00f3 gy\u00f3gyszer\u00e9szeti gyakorlatokat, a generikus gy\u00f3gyszer-helyettes\u00edt\u00e9s szempontjait \u00e9s a WHO aj\u00e1nl\u00e1sai szerinti gy\u00f3gyszeralkalmaz\u00e1s elemz\u00e9s\u00e9t a betegbiztons\u00e1g n\u00f6vel\u00e9se \u00e9rdek\u00e9ben. Emellett modellezik az orvos-beteg-gy\u00f3gyszer\u00e9sz egy\u00fcttm\u0171k\u00f6d\u00e9s k\u00fcl\u00f6nb\u00f6z\u0151 form\u00e1it.<\/li>\n<li><strong>Eg\u00e9szs\u00e9gtudom\u00e1nyi kutat\u00f3csoport<\/strong><br \/>\nA kutat\u00f3csoport az eg\u00e9szs\u00e9g\u00fcgy \u00e9s a gy\u00f3gyszer\u00e9szi gyakorlat hat\u00e9konys\u00e1g\u00e1t \u00e9s eredm\u00e9nyess\u00e9g\u00e9t vizsg\u00e1lja, k\u00fcl\u00f6n\u00f6s tekintettel a k\u00f6lts\u00e9g-hat\u00e9konys\u00e1gi elemz\u00e9sekre (Pharmacoeconomics) \u00e9s az eg\u00e9szs\u00e9g\u00fcgyi technol\u00f3gia-\u00e9rt\u00e9kel\u00e9sre (Health Technology Assessment). Tov\u00e1bb\u00e1 foglalkoznak a gy\u00f3gyszer\u00e9szi gondoz\u00e1s hat\u00e1sainak elemz\u00e9s\u00e9vel, az \u00e9letmin\u0151s\u00e9g (Quality of Life) \u00e9s a \u201ewell-being\u201d kutat\u00e1s\u00e1val, valamint az adherenci\u00e1t befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k, p\u00e9ld\u00e1ul a gy\u00f3gyszer\u00e9szi kommunik\u00e1ci\u00f3 \u00e9s az eg\u00e9szs\u00e9g\u00e9rt\u00e9s vizsg\u00e1lat\u00e1val.<\/li>\n<li><strong>Klinikai<\/strong> <strong>gy\u00f3gyszer-technol\u00f3gia kutat\u00f3csoport<\/strong><br \/>\nA csoport f\u0151 c\u00e9lja az individu\u00e1lis klinikai ter\u00e1pia t\u00e1mogat\u00e1sa gy\u00f3gyszerformul\u00e1l\u00e1si megold\u00e1sokkal. Kutat\u00e1saik a betegk\u00f6zpont\u00fa gy\u00f3gyszeradagol\u00e1si form\u00e1k fejleszt\u00e9s\u00e9re \u00e9s a k\u00fcl\u00f6nb\u00f6z\u0151 gy\u00f3gyszerform\u00e1k stabilit\u00e1s\u00e1nak vizsg\u00e1lat\u00e1ra ir\u00e1nyulnak. K\u00fcl\u00f6n\u00f6s figyelmet ford\u00edtanak a seg\u00e9danyagok optimaliz\u00e1l\u00e1s\u00e1ra, amelyek meghat\u00e1roz\u00f3 szerepet j\u00e1tszanak a gy\u00f3gyszerek hat\u00e9konys\u00e1g\u00e1ban \u00e9s stabilit\u00e1s\u00e1ban<\/li>\n<li><strong>Nanotechnol\u00f3gia kutat\u00f3csoport<\/strong><br \/>\nA csoport elektrosztatikus sz\u00e1lk\u00e9pz\u00e9si technik\u00e1kkal polimer alap\u00fa nanosz\u00e1las hat\u00f3anyaghordoz\u00f3 rendszereket fejleszt, amelyek innovat\u00edv megold\u00e1sokat k\u00edn\u00e1lnak a rossz v\u00edzoldhat\u00f3s\u00e1g\u00fa hat\u00f3anyagok biohasznos\u00edthat\u00f3s\u00e1g\u00e1nak n\u00f6vel\u00e9s\u00e9re. A kutat\u00e1s kiterjed a nanosz\u00e1las rendszerek szerkezet\u00e9nek \u00e9s stabilit\u00e1s\u00e1nak vizsg\u00e1lat\u00e1ra, valamint a liposz\u00f3m\u00e1k \u00e9s vezikul\u00e1k nanosz\u00e1las rendszerekbe t\u00f6rt\u00e9n\u0151 integr\u00e1l\u00e1s\u00e1ra. F\u0151 c\u00e9ljuk innovat\u00edv nanosz\u00e1l-alap\u00fa gy\u00f3gyszerform\u00e1k l\u00e9trehoz\u00e1sa.<\/li>\n<\/ol>\n<p>A kutat\u00f3csoportok k\u00f6z\u00f6s c\u00e9lja, hogy el\u0151seg\u00edts\u00e9k a modern gy\u00f3gyszertechnol\u00f3gia fejl\u0151d\u00e9s\u00e9t, hozz\u00e1j\u00e1ruljanak a betegek gy\u00f3gyszeres ter\u00e1pi\u00e1j\u00e1nak optimaliz\u00e1l\u00e1s\u00e1hoz, \u00e9s innovat\u00edv megold\u00e1sokat fejlesszenek a j\u00f6v\u0151 gy\u00f3gyszereinek hat\u00e9konyabb \u00e9s biztons\u00e1gosabb alkalmaz\u00e1s\u00e1hoz.<\/p>\n<h3 style=\"text-align: left\">KUTAT\u00d3CSOPORTOK:<\/h3>\n<div class=\"responsive-tabs\">\n<h2 class=\"tabtitle\">Gy\u00f3gyszer\u00e9szi gondoz\u00e1s, klinikai gy\u00f3gyszer\u00e9szet kutat\u00f3csoport<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>Gy\u00f3gyszer\u00e9szi gondoz\u00e1s, klinikai gy\u00f3gyszer\u00e9szet kutat\u00f3csoport<\/strong><\/p>\n<p><strong>Kutat\u00f3csoport vezet\u0151je: Dr. Hank\u00f3 Bal\u00e1zs<\/strong><\/p>\n<p><strong>Tagok:<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"274\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD, DSc, egyetemi tan\u00e1r, igazgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Hank\u00f3 Bal\u00e1zs<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD, egyetemi tan\u00e1r<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Seb\u0151k Szilvia<\/p>\n<\/td>\n<td width=\"330\">\n<p>f\u0151gy\u00f3gyszer\u00e9sz, igazgat\u00f3helyettes, mesteroktat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Kleiner D\u00e9nes<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD, egyetemi adjunktus<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Somogyi Orsolya<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD, egyetemi adjunktus<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Vajda P\u00e9ter<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD, egyetemi tan\u00e1rseg\u00e9d,<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Turbucz B\u00e9la<\/p>\n<\/td>\n<td width=\"330\">\n<p>doktorjel\u00f6lt<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Horv\u00e1th Istv\u00e1n L\u00e1szl\u00f3<\/p>\n<\/td>\n<td width=\"330\">\n<p>szakgy\u00f3gyszer\u00e9sz, PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Budai Kinga Anna<\/p>\n<\/td>\n<td width=\"330\">\n<p>szakgy\u00f3gyszer\u00e9sz, PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>Dr. Artner Anna<\/p>\n<\/td>\n<td width=\"330\">\n<p>PhD hallgat\u00f3, rezidens<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"274\">\n<p>So\u00f3s Hanna<\/p>\n<\/td>\n<td width=\"330\">\n<p>TDK hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>A kutat\u00e1si tev\u00e9kenys\u00e9g\u00fcnk mag\u00e1ban foglalja:<\/strong><\/p>\n<ul>\n<li>A kr\u00f3nikus betegek gy\u00f3gyszeres kezel\u00e9s\u00e9nek szempontjait, a gy\u00f3gyszeres ter\u00e1pia nyomon k\u00f6vet\u00e9s\u00e9t,<\/li>\n<li>A gy\u00f3gyszerel\u00e9si probl\u00e9ma felismer\u00e9s\u00e9nek, megel\u0151z\u00e9s\u00e9nek \u00e9s megold\u00e1s\u00e1nak m\u00f3dszereit,<\/li>\n<li>A beteg ter\u00e1pi\u00e1s egy\u00fcttm\u0171k\u00f6d\u0151-k\u00e9szs\u00e9g\u00e9nek m\u00e9r\u00e9s\u00e9t, valamint jav\u00edt\u00e1s\u00e1t,<\/li>\n<li>A bizony\u00edt\u00e9kokon alapul\u00f3 gy\u00f3gy\u00edt\u00e1s k\u00f6zforgalm\u00fa gy\u00f3gyszer\u00e9szeti vonatkoz\u00e1sait \u00e9s a generikus gy\u00f3gyszer-helyettes\u00edt\u00e9s speci\u00e1lis szempontjait,<\/li>\n<li>A gy\u00f3gyszeralkalmaz\u00e1s WHO aj\u00e1nl\u00e1sai szerint t\u00f6rt\u00e9n\u0151 elemz\u00e9s\u00e9t a betegbiztons\u00e1g n\u00f6vel\u00e9s\u00e9re, valamint<\/li>\n<li>Az orvos-beteg-gy\u00f3gyszer\u00e9sz egy\u00fcttm\u0171k\u00f6d\u00e9s modelljeit.<\/li>\n<\/ul>\n<p><strong>Kutat\u00e1si t\u00e1mogat\u00e1sok, p\u00e1ly\u00e1zatok:<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Kutat\u00e1s c\u00edme: A gy\u00f3gyszer\u00e9szek szerepe az id\u0151s betegek sztatinter\u00e1pi\u00e1s adherenci\u00e1j\u00e1nak jav\u00edt\u00e1s\u00e1ban: egy randomiz\u00e1lt, kontroll\u00e1lt vizsg\u00e1lat<br \/>\nSE RKEB eng. sz.: 192\/2024.\u00a0<br \/>\nKutat\u00e1s vezet\u0151je: Dr. Zelk\u00f3 Rom\u00e1na \u00e9s Dr. Torzsa P\u00e9ter<\/p>\n<p>Kutat\u00e1s c\u00edme<em>:<\/em> LACT-ED vizsg\u00e1lat: V\u00e9ny n\u00e9lk\u00fcli gy\u00f3gyszerekkel kapcsolatos szoptat\u00e1si tan\u00e1csad\u00e1s az interneten: mi a legjobb m\u00e9dium?<br \/>\nSE RKEB eng. sz.: 9\/2024<br \/>\nKutat\u00e1svezet\u0151: Dr. Kleiner D\u00e9nes<\/p>\n<p>OTKA K 147355 kutat\u00e1si p\u00e1ly\u00e1zat<br \/>\nP\u00e1ly\u00e1zat c\u00edme: R\u00f6vid id\u0151tartam\u00fa, intenz\u00edv sztatinkezel\u00e9s koron\u00e1riaplakk-saj\u00e1toss\u00e1gokra kifejtett hat\u00e1s\u00e1nak vizsg\u00e1lata sz\u00edv-CT-vel<br \/>\nKutat\u00e1svezet\u0151: Maurovich-Horvat P\u00e1l, r\u00e9sztvev\u0151: Dr. Seb\u0151k Szilvia<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>Kutat\u00e1s c\u00edme: F\u00f3kuszcsoportos megbesz\u00e9l\u00e9s az interakci\u00f3k optim\u00e1lis kezel\u00e9s\u00e9re,<br \/>\nSE RKEB eng. sz.: 2015\/2023,<br \/>\nKutat\u00e1svezet\u0151: Dr. Kleiner D\u00e9nes<br \/>\nR\u00e9sztvev\u0151k: Dr. Horv\u00e1th Istv\u00e1n L\u00e1szl\u00f3, Dr. Seb\u0151k Szilvia, Dr. Sz\u00e9pe Orsolya<br \/>\nHaghverdi Faraz<\/p>\n<p>RRF oktat\u00e1sfejleszt\u00e9si p\u00e1ly\u00e1zat 2023. \u201eKlinikai gy\u00f3gyszer\u00e9szet\u201d k\u00f6telez\u0151 kurzus fejleszt\u00e9se: A \u201eklinikai gy\u00f3gyszer\u00e9szet\u201d k\u00f6telez\u0151 t\u00e1rgy fejleszt\u00e9se a Moodle rendszerben.<br \/>\nVezet\u0151: Dr. Hank\u00f3 Bal\u00e1zs; tov\u00e1bbi r\u00e9sztvev\u0151k: Dr. Seb\u0151k Szilvia; Dr. Kleiner D\u00e9nes; Dr. Horv\u00e1th Istv\u00e1n L\u00e1szl\u00f3; Dr. Zelk\u00f3 Rom\u00e1na; Dr. Langer Andr\u00e1s.<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>P\u00e1ly\u00e1zat c\u00edme: \u00c1ltal\u00e1nos oktat\u00e1sfejleszt\u00e9si p\u00e1ly\u00e1zat 2022. Klinikai gy\u00f3gyszer\u00e9szet k\u00f6telez\u0151 kurzus fejleszt\u00e9se.<br \/>\nKapcsolattart\u00f3: Dr. Seb\u0151k Szilvia<br \/>\nR\u00e9sztvev\u0151k: Dr. Hank\u00f3 Bal\u00e1zs; Dr. Horv\u00e1th Istv\u00e1n L\u00e1szl\u00f3; Dr. Kleiner D\u00e9nes; Dr. Langer Andr\u00e1s.<\/p>\n<p>P\u00e1ly\u00e1zat c\u00edme: \u201ePost-covid szindr\u00f3m\u00e1s betegek adatainak retrospekt\u00edv elemz\u00e9se a klinikai ell\u00e1t\u00e1si protokollban szerepl\u0151 adatok feldolgoz\u00e1s\u00e1val\u201d<br \/>\n145\/2022<br \/>\nR\u00e9sztvev\u0151: Dr. Seb\u0151k Szilvia<\/p>\n<p>Kutat\u00e1s c\u00edme: H\u00e1ziorvos \u2013 gy\u00f3gyszer\u00e9sz egy\u00fcttm\u0171k\u00f6d\u00e9si projektmunka, Polifarm\u00e1ci\u00e1val kezelt betegek gy\u00f3gyszerbiztons\u00e1gi ellen\u0151rz\u00e9se projektmunka<br \/>\nSE RKEB eng. sz.: 31\/2022<br \/>\nR\u00e9sztvev\u0151k: Dr. Hank\u00f3 Bal\u00e1zs, Dr. Somogyi Orsolya<\/p>\n<p>Kutat\u00e1s c\u00edme: Eg\u00e9szs\u00e9g\u00e9rt\u00e9st jav\u00edt\u00f3 projektmunka k\u00f6zforgalm\u00fa gy\u00f3gyszert\u00e1rakban<br \/>\nSE RKEB eng. sz.: 32\/2022<br \/>\nR\u00e9sztvev\u0151k: Dr. Hank\u00f3 Bal\u00e1zs, Dr. Somogyi Orsolya<\/p>\n<p><strong>Sikeresen megv\u00e9dett Ph.D. \u00e9rtekez\u00e9sek (2020-2024 k\u00f6z\u00f6tt):<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>Sarah Al Assaf:\u00a0Pharmacist services in the enhancement of type 2 diabetes patients\u2019 therapeutic adherence<br \/>\nT\u00e9mavezet\u0151: Dr. Hank\u00f3 Bal\u00e1zs Zolt\u00e1n<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Szilvay Andr\u00e1s:<strong>\u00a0<\/strong>Evidence-based development oppotunities for medication review in the framework of basic pharmaceutical care in Hungarian community pharmacies<br \/>\nT\u00e9mavezet\u0151: Dr. Hank\u00f3 Bal\u00e1zs Zolt\u00e1n, Konzulens: Dr. Somogyi Orsolya<\/p>\n<p><strong>V\u00e1logatott publik\u00e1ci\u00f3k:<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2025<\/strong><\/p>\n<p>Vajda\u00a0P, Bodor Zs. Subcutan alkalmazhat\u00f3 onkol\u00f3giai gy\u00f3gyszerek. Gy\u00f3gyszer\u00e9szet 69:27\u201331. (2025)<\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Horv\u00e1th IL, Kleiner D, Nagy R, Feh\u00e9rv\u00e1ri P, Hank\u00f3 B, Hegyi P, Csupor D. Nafamostat Reduces the Incidence of post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Pharmacology &amp; Therapeutics. 2024;115(2):206-12.<\/p>\n<p>Guly\u00e1s E, Horv\u00e1th IL, Engh MA, Bunduc S, Dembrovszky F, Feh\u00e9rv\u00e1ri P, et al. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies. SCI REP. 2024;14(1):7793.<\/p>\n<p>Vajda\u00a0P, Botz L. Gy\u00f3gyszerhullad\u00e9k-monitoroz\u00e1s a k\u00f6rnyezettudatoss\u00e1g jegy\u00e9ben. Orvosi Hetilap 165 : 17 pp. 672-679. , 8 p. (2024)\u00a0<\/p>\n<p>T\u00edm\u00e1r \u00c1E, P\u00e1rniczky A, Budai KA, Hern\u00e1df\u0151i MV, Kaszn\u00e1r E, Varga P, et al. Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations. Journal of Crohn&#8217;s and Colitis. 2024;18(6):851-63.<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>Seb\u0151k S, Gyires K. Long COVID and possible preventive options. Inflammopharmacology. 2023 Dec;31(6):2807-2817. doi: 10.1007\/s10787-023-01204-1.<\/p>\n<p>L\u0151rinczy L, Turbucz B, Hank\u00f3 B, Zelk\u00f3 R. Managing Antibiotic Shortages in Inpatient Care\u2014A Review of Recent Years in Comparison with the Hungarian Status. Antibiotics. 2023;12(12):1704.<\/p>\n<p>Horv\u00e1th IL, Bunduc S, Hank\u00f3 B, Kleiner D, Demcs\u00e1k A, Szab\u00f3 B, et al. No evidence for the benefit of PPIs in the treatment of acute pancreatitis: a systematic review and meta-analysis. SCI REP. 2023;13(1):2791.<\/p>\n<p>Kleiner D, Horv\u00e1th IL, Bunduc S, Gerg\u0151 D, Lugosi K, Feh\u00e9rv\u00e1ri P, et al. Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. Curr Neuropharmacol. 2023;21(12):2505-15.<\/p>\n<p>Al Assaf S, Kleiner D, Zelk\u00f3 R, Hank\u00f3 B. Type 2 Diabetes Patients\u2019 Views of Local Pharmacists and Fulfilment with Pharmaceutical Diabetes Care in Syria\u2019s Latakia Governorate: An Online Survey Research. Healthcare. 2023;11(12):1720.<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Turbucz B, Major M, Zelko R, Hanko B. Proposal for Handling of Medicine Shortages Based on a Comparison of Retrospective Risk Analysis. International Journal of Environmental Research and Public Health. 2022;19(7):4102.<\/p>\n<p>Horv\u00e1th IL, Bunduc S, Feh\u00e9rv\u00e1ri P, V\u00e1ncsa S, Nagy R, Garmaa G, et al. The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. SCI REP. 2022;12(1):17979.<\/p>\n<p>Kleiner D, Somogyi O, Petlickij FH, Mesk\u00f3 A, Szilvay A, Zelk\u00f3 R, Hank\u00f3 B. Implementation of a personal health planning program and health promotion in the community pharmacies. Heliyon. 2022;8(7).<\/p>\n<p style=\"text-align: center\"><strong>2021<\/strong><\/p>\n<p>Szilvay A, Somogyi O, Dobszay A, Mesk\u00f3 A, Zelk\u00f3 R, Hank\u00f3 B. Analysis of interaction risks of patients with polypharmacy and the pharmacist interventions performed to solve them\u2014A multicenter descriptive study according to medication reviews in Hungarian community pharmacies. PLOS ONE. 2021;16(6):e0253645.<\/p>\n<p style=\"text-align: center\"><strong>2020<\/strong><\/p>\n<p>Turbucz B,\u00a0Hank\u00f3, B. Overview of the causes and management of drug shortages in the United States and in Hungary.\u00a0ACTA PHARMACEUTICA HUNGARICA, 2020; 90 (4). pp. 170-184. ISSN 0001-6659<\/p>\n<p>Szilvay A, Somogyi O, Mesk\u00f3 A, Sz\u0171cs-Polonkai K, Zelk\u00f3 R, Hank\u00f3 B. Establishment of a communication environment supporting low-health literacy in the Hungarian community pharmacies: the introduction of a methodological recommendation: a before\u2013after study. BMJ Open. 2020;10(12):e039603.<\/p>\n<p>Kleiner D. A cannabidiolr\u00f3l szakszer\u0171en STUDIUM &amp; PRACTICUM: F\u00dcGGETLEN GY\u00d3GYSZER\u00c9SZETI FOLY\u00d3IRAT\u00a014\u00a0:\u00a02\u00a0pp. 26-27. , 2 p.\u00a0(2020) reprint in: A kenderolajr\u00f3l hitelesen: Egy ismert ismeretlen &#8211; a CBD-olaj PATIKA MAGAZIN\u00a025\u00a0:\u00a03\u00a0pp. 24-25. , 2 p.\u00a0(2020) &amp; A cannabidiololajr\u00f3l szakszer\u0171en GY\u00d3GYSZERT\u00c1RI PRACTICUM NOVUM\u00a024\u00a0:\u00a06\u00a0pp. 16-17. , 2 p.\u00a0(2020)<\/p>\n<p>Kleiner D, Dank M,\u00a0;\u00a0\u00c9get\u0151 E;\u00a0Hank\u00f3 B. Betegt\u00e1j\u00e9koztat\u00f3 el\u0151ad\u00e1sok az onkol\u00f3giai ell\u00e1t\u00e1ssal kapcsolatban\u00a0(2020)<\/p>\n<p>Bl\u00e1zovics A,\u00a0Sipos P,\u00a0Kocsis I,\u00a0F\u00e9bel H, Kleiner, D\u00a0;\u00a0Szentmih\u00e1lyi K,\u00a0Feh\u00e9r, E.,<br \/>\nA zs\u00edrd\u00fas \u00e9trend induk\u00e1lta steatosis \u00e9s a b\u00e9l\u2013m\u00e1j tengely v\u00e1ltoz\u00e1sai ORVOSI HETILAP\u00a0161\u00a0:\u00a035\u00a0pp. 1456-1465. , 10 p.\u00a0(2020)<\/p>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n\n<\/div><h2 class=\"tabtitle\">Eg\u00e9szs\u00e9gtudom\u00e1nyi Kutat\u00f3csoport<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>Eg\u00e9szs\u00e9gtudom\u00e1nyi kutat\u00f3csoport<\/strong><\/p>\n<p><strong>Kutat\u00f3csoport vezet\u0151je: Dr. M\u00e9sz\u00e1ros \u00c1gnes<\/strong><\/p>\n<p><strong>Tagok:<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"302\">\n<p>Dr. M\u00e9sz\u00e1ros \u00c1gnes<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, egyetemi docens<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. Sz\u00e9pe Orsolya<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, egyetemi adjunktus<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Jan Sifert<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Niklas Zimmermann<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Kutat\u00f3csoport tev\u00e9kenys\u00e9g\u00e9nek bemutat\u00e1sa:<\/strong><\/p>\n<p>Kutat\u00f3csoportunk f\u00f3kusz\u00e1ban olyan elemz\u00e9sek \u00e9s vizsg\u00e1latok \u00e1llnak, amelyek az eg\u00e9szs\u00e9g\u00fcggyel, gy\u00f3gyszer\u00e9szi gyakorlattal, azok hat\u00e9konys\u00e1g\u00e1val, eredm\u00e9nyess\u00e9g\u00e9vel foglalkoznak.<\/p>\n<p>Munk\u00e1nk kiterjed:<\/p>\n<ul>\n<li>a k\u00f6lts\u00e9g-hat\u00e9konys\u00e1g vizsg\u00e1lat\u00e1ra (Pharmacoeconomics),<\/li>\n<li>eg\u00e9szs\u00e9g\u00fcgyi technol\u00f3gia-elemz\u00e9sre (Health Technology Assessment) \u00edgy p\u00e9ld\u00e1ul a Gy\u00f3gyszer\u00e9szi Gondoz\u00e1si tev\u00e9kenys\u00e9g,<\/li>\n<li>\u00e9letmin\u0151s\u00e9g (Quality of life Assessment) \u00e9s \u201eWell-being\u201d kutat\u00e1s\u00e1ra,<\/li>\n<li>az adherenci\u00e1t befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k, \u00fagymint a Gy\u00f3gyszer\u00e9szi Kommunik\u00e1ci\u00f3 \u00e9s az eg\u00e9szs\u00e9g\u00e9rt\u00e9s vizsg\u00e1lat\u00e1ra,<\/li>\n<li>a gy\u00f3gyszer\u00e9szi gondoz\u00e1s \u00e9s gy\u00f3gyszer\u00e9szi kommunik\u00e1ci\u00f3,<\/li>\n<li>j\u00f3ll\u00e9t kutat\u00e1s (well-being assessment) t\u00e9mak\u00f6reire.<\/li>\n<\/ul>\n<p><strong>Kutat\u00e1si t\u00e1mogat\u00e1sok, p\u00e1ly\u00e1zatok: <\/strong><\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>J\u00f3-l\u00e9t, ment\u00e1lis-eg\u00e9szs\u00e9g \u00e9s az \u00e9letmin\u0151s\u00e9g, valamint a befoly\u00e1sol\u00f3 t\u00e9nyez\u0151k felm\u00e9r\u00e9se egyetemi hallgat\u00f3k k\u00f6r\u00e9ben.<br \/>\nSE RKEB sz\u00e1m: 173\/2022.<br \/>\nKutat\u00e1svezet\u0151: Dr. M\u00e9sz\u00e1ros \u00c1gnes<\/p>\n<p><strong>Sikeresen megv\u00e9dett Ph.D. \u00e9rtekez\u00e9sek:<\/strong><\/p>\n<p><strong>&#8211;<\/strong><\/p>\n<p><strong>V\u00e1logatott publik\u00e1ci\u00f3k: <\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Szepe O, Meszaros A. Assessing well-being of university students and evaluation of its determinants. BMC Public Health. 2024;24(1):2862.<\/p>\n<p>Shmorgun Annam\u00e1ria, M\u00e9sz\u00e1ros \u00c1gnes, Felkai P\u00e9ter: K\u00fclf\u00f6ldre vihet\u0151 gy\u00f3gyszerek \u2013 adatb\u00e1zis az utaz\u00e1s el\u0151tti tan\u00e1csad\u00e1st v\u00e9gz\u0151 szakemberek sz\u00e1m\u00e1ra. ORVOSI HETILAP 165 : 20 pp. 769-774. , 6 p. (2024)<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>M\u00e9sz\u00e1ros, \u00c1gnes: Gy\u00f3gyszerter\u00e1pi\u00e1s d\u00f6nt\u00e9shozatal, r\u00e9gi-\u00faj gy\u00f3gyszer\u00e9szi szerepek. GY\u00d3GYSZER\u00c9SZET 66 pp. 176-180. , 5 p. (2022)<\/p>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n\n<\/div><h2 class=\"tabtitle\">Klinikai Gy\u00f3gyszer-technol\u00f3gia Kutat\u00f3csoport<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>Klinikai gy\u00f3gyszer-technol\u00f3gia kutat\u00f3csoport<\/strong><\/p>\n<p><strong>Kutat\u00f3csoport vezet\u0151je: Dr. Zelk\u00f3 Rom\u00e1na<\/strong><\/p>\n<p><strong>Munkat\u00e1rsak:<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"302\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, DSc, egyetemi tan\u00e1r, igazgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. Vajna M\u00e1rton Antal<\/p>\n<\/td>\n<td width=\"302\">\n<p>szakgy\u00f3gyszer\u00e9sz<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. Sebe Istv\u00e1n<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, tudom\u00e1nyos munkat\u00e1rs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. Benk\u0151 Be\u00e1ta-M\u00e1ria<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Pegah Poursafar<\/p>\n<\/td>\n<td width=\"302\">\n<p>TDK hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Kutat\u00f3csoport tev\u00e9kenys\u00e9g\u00e9nek bemutat\u00e1sa:<\/strong><\/p>\n<ul>\n<li>Az individu\u00e1lis klinikai ter\u00e1pia biztos\u00edt\u00e1s\u00e1hoz gy\u00f3gyszerformul\u00e1l\u00e1si tev\u00e9kenys\u00e9g v\u00e9gz\u00e9se,<\/li>\n<li>Az ipari gy\u00f3gyszerfejleszt\u00e9si folyamat \u00e9s projektmenedzsment szempontjait integr\u00e1lva innovat\u00edv gy\u00f3gyszerhordoz\u00f3 rendszerek fejleszt\u00e9se, el\u0151\u00e1ll\u00edt\u00e1sa \u00e9s <em>in vitro<\/em> vizsg\u00e1lata,<\/li>\n<li>Betegk\u00f6zpont\u00fa gy\u00f3gyszeradagol\u00e1si form\u00e1k fejleszt\u00e9se,<\/li>\n<li>A k\u00fcl\u00f6nb\u00f6z\u0151 gy\u00f3gyszerform\u00e1k stabilit\u00e1s\u00e1nak vizsg\u00e1lata, k\u00fcl\u00f6n\u00f6s tekintettel seg\u00e9danyag-kiv\u00e1laszt\u00e1s optimaliz\u00e1l\u00e1s\u00e1ra.<\/li>\n<\/ul>\n<p><strong>Kutat\u00e1si t\u00e1mogat\u00e1sok, p\u00e1ly\u00e1zatok: <\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Egyetemi Kutat\u00f3i \u00d6szt\u00f6nd\u00edj Program<br \/>\nP\u00e1ly\u00e1zat c\u00edme: Adjuv\u00e1ns melanoma kezel\u00e9s diszulfir\u00e1m tartalm\u00fa ciklodextrin alap\u00fa gy\u00f3gyszerhordoz\u00f3 rendszerek alkalmaz\u00e1s\u00e1val<br \/>\nKedvezm\u00e9nyezett: Dr. Benk\u0151 Be\u00e1ta M\u00e1ria<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1ly\u00e1zat c\u00edme: Diszulfir\u00e1m \u00fajrapoz\u00edcion\u00e1l\u00e1sa Lyme-k\u00f3r kezel\u00e9s\u00e9re innovat\u00edv \u00e9s nem invaz\u00edv gy\u00f3gyszerforma fejleszt\u00e9s\u00e9vel<br \/>\nKedvezm\u00e9nyezett: Dr. Benk\u0151 Be\u00e1ta M\u00e1ria<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Semmelweis KFI p\u00e1ly\u00e1zat STIA<br \/>\nP\u00e1ly\u00e1zat c\u00edme: A diszulfir\u00e1m \u00fajrapozicion\u00e1l\u00e1sa a glioblaszt\u00f3ma kezel\u00e9s\u00e9re egy hozz\u00e1adott \u00e9rt\u00e9k\u0171 intranaz\u00e1lis gy\u00f3gyszerforma megtervez\u00e9s\u00e9vel<br \/>\nKutat\u00e1svezet\u0151: Dr. Sebe Istv\u00e1n<\/p>\n<p><strong>Sikeresen megv\u00e9dett Ph.D. \u00e9rtekez\u00e9sek (2020-2024 k\u00f6z\u00f6tt):<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Palcs\u00f3 Barnab\u00e1s:<strong>\u00a0<\/strong>Formulation and characterization of chlorine-dioxide-releasing, polymer-based delivery systems\u201d<br \/>\nT\u00e9mavezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p><strong>V\u00e1logatott publik\u00e1ci\u00f3k:<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Csorba A, Katona G, Budai-Sz\u0171cs M, Balogh-Weiser D, Moln\u00e1r P, Maka E, et al. A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis. International Journal of Molecular Sciences. 2024;25(3):1623.<\/p>\n<p>Benk\u0151 B-M, T\u00f3th G, Moldvai D, K\u00e1d\u00e1r S, Szab\u00f3 E, Szab\u00f3 Z-I, et al. Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes. International Journal of Pharmaceutics. 2024;657:124187.<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>Benk\u0151 B-M, Lamprou DA, Sebesty\u00e9n A, Zelk\u00f3 R, Sebe I. Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma &#8211; a systematic literature review. Expert Opinion on Drug Delivery. 2023;20(4):541-57.<\/p>\n<p>Shokoya MM, Benk\u0151 B-M, S\u00fcvegh K, Zelk\u00f3 R, Sebe I. Positron Annihilation Lifetime Spectroscopy as a Special Technique for the Solid-State Characterization of Pharmaceutical Excipients, Drug Delivery Systems, and Medical Devices\u2014A Systematic Review. Pharmaceuticals [Internet]. 2023; 16(2).<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Palcs\u00f3 B, Kazsoki A, Herczegh A, Ghid\u00e1n \u00c1, Pinke B, M\u00e9sz\u00e1ros L, Zelk\u00f3 R. Formulation of Chlorine-Dioxide-Releasing Nanofibers for Disinfection in Humid and CO2-Rich Environment. NANOMATERIALS-BASEL. 2022;12(9):1481.<\/p>\n<p>Benk\u0151 B-M,\u00a0Sebe I, Szab\u00f3, Z-I. Insulin for topical use in wound healing: opportunities and limitations, ACTA PHARMACEUTICA HUNGARICA\u00a092\u00a0:\u00a01\u00a0pp. 3-19., 17 p.\u00a0(2022)<\/p>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n\n<\/div><h2 class=\"tabtitle\">Nanotechnol\u00f3gia Kutat\u00f3csoport<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>Nanotechnol\u00f3gia, nanosz\u00e1las kutat\u00f3csoport<\/strong><\/p>\n<p><strong>Kutat\u00f3csoport vezet\u0151je: Dr. Zelk\u00f3 Rom\u00e1na<\/strong><\/p>\n<p><strong>Tagok: <\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"302\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, DSc, egyetemi tan\u00e1r, igazgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD, egyetemi adjunktus<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Houssam Abboud<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Dr. K\u00fcrt\u00f6si Bal\u00e1zs<\/p>\n<\/td>\n<td width=\"302\">\n<p>PhD hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"302\">\n<p>Farkas Eszter Zita<\/p>\n<\/td>\n<td width=\"302\">\n<p>TDK hallgat\u00f3<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Kutat\u00f3csoport tev\u00e9kenys\u00e9g\u00e9nek bemutat\u00e1sa:<\/strong><\/p>\n<ul>\n<li>Polimer alap\u00fa, nanosz\u00e1las hat\u00f3anyaghordoz\u00f3 rendszerek formul\u00e1l\u00e1sa elektrosztatikus sz\u00e1lk\u00e9pz\u00e9ssel, valamint koaxi\u00e1lis elektrosztatikus sz\u00e1lk\u00e9pz\u00e9ssel,<\/li>\n<li>Rossz v\u00edzoldhat\u00f3s\u00e1g\u00fa hat\u00f3anyagok oldhat\u00f3s\u00e1g\u00e1nak, biohasznos\u00edthat\u00f3s\u00e1g\u00e1nak n\u00f6vel\u00e9se,<\/li>\n<li>A sz\u00e1las rendszerek komplex szil\u00e1rd-f\u00e1zis\u00fa jellemz\u00e9se a formul\u00e1ci\u00f3 szempontj\u00e1b\u00f3l fontos ok-okozati \u00f6sszef\u00fcgg\u00e9sek, valamint a stabilit\u00e1s sor\u00e1n bek\u00f6vetkez\u0151 v\u00e1ltoz\u00e1sok nyomon k\u00f6vet\u00e9s\u00e9re,<\/li>\n<li>A nanosz\u00e1las szerkezet funkci\u00f3val \u00f6sszef\u00fcgg\u0151 tulajdons\u00e1gainak a felt\u00e1r\u00e1sa,<\/li>\n<li>Liposz\u00f3ma \u00e9s vezikul\u00e1k formul\u00e1l\u00e1sa, sz\u00e9lesk\u00f6r\u0171 jellemz\u00e9se, valamint nanosz\u00e1las rendszerbe val\u00f3 \u00e1gyaz\u00e1sa,<\/li>\n<li>Innovat\u00edv nanosz\u00e1l-alap\u00fa gy\u00f3gyszerek formul\u00e1l\u00e1sa.<\/li>\n<\/ul>\n<p><strong>Kutat\u00e1si t\u00e1mogat\u00e1sok, p\u00e1ly\u00e1zatok:<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Egyetemi Kutat\u00f3i \u00d6szt\u00f6nd\u00edj Program<br \/>\nP\u00e1ly\u00e1zat c\u00edme: Nanosz\u00e1las tapasz fejleszt\u00e9se sz\u00e1j\u00fcregi afta kezel\u00e9s\u00e9re<br \/>\nKedvezm\u00e9nyezett: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1lyam\u0171 c\u00edme: Nanosz\u00e1las szem\u00e9szeti inzert formul\u00e1l\u00e1sa id\u0151skori makuladegener\u00e1ci\u00f3 kezel\u00e9s\u00e9re<br \/>\nKedvezm\u00e9nyezett: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program\u00a0<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Development and formulation of nanofiber-based opthalmic inserts for treatment of fungal keratitis<br \/>\nKedvezm\u00e9nyezett: Safaa Mohammed Omer Musa<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Semmelweis KFI p\u00e1ly\u00e1zat STIA<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Kurkuminnal t\u00f6lt\u00f6tt extracellul\u00e1ris vezikula tartalm\u00fa nanosz\u00e1las h\u00e1l\u00f3 formul\u00e1l\u00e1sa<br \/>\nKutat\u00e1svezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1lyam\u0171 c\u00edme: Innovat\u00edv nanosz\u00e1l-alap\u00fa szem\u00e9szeti k\u00e9sz\u00edtm\u00e9nyek formul\u00e1l\u00e1sa elektrosztatikus sz\u00e1lk\u00e9pz\u00e9ssel<br \/>\nKedvezm\u00e9nyezett: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Development of Innovative electrospun nanofiber-based nepafenac-loaded ophthalmic inserts<br \/>\nKedvezm\u00e9nyezett: Safaa Mohammed Omer Musa<\/p>\n<p style=\"text-align: center\"><strong>2021<\/strong><\/p>\n<p>Semmelweis KFI p\u00e1ly\u00e1zat STIA<br \/>\nP\u00e1lyam\u0171 c\u00edme: Extracellul\u00e1ris vezikul\u00e1val t\u00f6lt\u00f6tt, elektrosztatikus sz\u00e1lk\u00e9pz\u00e9ssel el\u0151\u00e1ll\u00edtott nanosz\u00e1lak szerkezet-aktivit\u00e1s \u00f6sszef\u00fcgg\u00e9s\u00e9nek nyomon k\u00f6vet\u00e9se a t\u00e1rol\u00e1s f\u00fcggv\u00e9ny\u00e9ben<br \/>\nKutat\u00e1svezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p>Semmelweis KFI p\u00e1ly\u00e1zat STIA<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Nanosz\u00e1las szem\u00e9szeti inzertek formul\u00e1l\u00e1sa<br \/>\nKutat\u00e1svezet\u0151: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Nanosz\u00e1l alap\u00fa, innovat\u00edv szem\u00e9szeti k\u00e9sz\u00edtm\u00e9nyek formul\u00e1l\u00e1sa<br \/>\nKedvezm\u00e9nyezett: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p style=\"text-align: center\"><strong>2020<\/strong><\/p>\n<p>Semmelweis KFI p\u00e1ly\u00e1zat STIA 2020<br \/>\nP\u00e1lyam\u0171 c\u00edme:\u00a0Intraor\u00e1lis alkalmaz\u00e1sra sz\u00e1nt mag-h\u00e9j t\u00edpus\u00fa nanosz\u00e1las lapka formul\u00e1l\u00e1sa allergia kezel\u00e9s\u00e9re<br \/>\nKutat\u00e1svezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p>\u00daj Nemzeti Kiv\u00e1l\u00f3s\u00e1gi Program<br \/>\nP\u00e1lyam\u0171 c\u00edme: Mag-h\u00e9j t\u00edpus\u00fa nanosz\u00e1l alap\u00fa tapasz formul\u00e1l\u00e1sa ajakherpesz kezel\u00e9s\u00e9re<br \/>\nKedvezm\u00e9nyezett: Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p><strong>Sikeresen megv\u00e9dett Ph.D. \u00e9rtekez\u00e9sek (2020-204 k\u00f6z\u00f6tt):<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Safaa Omer Musa: Formulation, development, and evaluation of innovative electrospun nanofiber-based ophthalmic inserts<br \/>\nT\u00e9mavezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na, Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<p style=\"text-align: center\"><strong>2020<\/strong><\/p>\n<p>Kazsoki Adrienn: Formulation and Microstructural distinction of nanofibrous drug delivery systems<br \/>\nT\u00e9mavezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p>Kov\u00e1cs Andrea: Formulation of furosemide loaded electrospun nanofibrous buccal drug delivery systems<br \/>\nT\u00e9mavezet\u0151: Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<p><strong>V\u00e1logatott publik\u00e1ci\u00f3k:<\/strong><\/p>\n<p style=\"text-align: center\"><strong>2024<\/strong><\/p>\n<p>Abboud HA, Zelk\u00f3 R, Kazsoki A. A systematic review of liposomal nanofibrous scaffolds as a drug delivery system: a decade of progress in controlled release and therapeutic efficacy. Drug Delivery. 2025;32(1):2445259.<\/p>\n<p>Farkas E, Abboud H, Nagy N, Hofmeister B, Ostorh\u00e1zi E, T\u00f3th B, et al. Formulation and Development of Nanofiber-Based Ophthalmic Insert for the Treatment of Bacterial Conjunctivitis. Int J Mol Sci. 2024;25(17).<\/p>\n<p>Kazsoki A, N\u00e9meth K, Visnovitz T, Lenzinger D, Buz\u00e1s EI, Zelk\u00f3 R. Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin. SCI REP. 2024;14(1):27574.<\/p>\n<p>K\u00fcrt\u00f6si B, Kazsoki A, Zelk\u00f3 R. A Systematic Review on Plant-Derived Extracellular Vesicles as Drug Delivery Systems. International Journal of Molecular Sciences. 2024;25(14):7559.<\/p>\n<p>Omer S, Nagy N, Pinke B, M\u00e9sz\u00e1ros L, Kazsoki A, Zelk\u00f3 R. Development and Evaluation of Different Electrospun Cysteamine-Loaded Nanofibrous Webs: A Promising Option for Treating a Rare Lysosomal Storage Disorder. Pharmaceutics. 2024;16(8):1052.<\/p>\n<p>Romeo A, Kazsoki A, Musumeci T, Zelk\u00f3 R. A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders\u2014A Systematic Review. International Journal of Molecular Sciences. 2024;25(7):3999.<\/p>\n<p style=\"text-align: center\"><strong>2023<\/strong><\/p>\n<p>Omer S, Nagy N, Sz\u0151cs E, K\u00e1d\u00e1r S, V\u00f6lgyi G, Pinke B, et al. Development of innovative electrospun nepafenac-loaded nanofibers-based ophthalmic inserts. International Journal of Pharmaceutics. 2023;647:123554.<\/p>\n<p>Romeo A, Kazsoki A, Omer S, Pinke B, M\u00e9sz\u00e1ros L, Musumeci T, Zelk\u00f3 R. Formulation and Characterization of Electrospun Nanofibers for Melatonin Ocular Delivery. Pharmaceutics. 2023;15(4):1296.<\/p>\n<p>T\u00f3th GD, K\u00e1llai-Szab\u00f3 N, Lengyel M, S\u00fcvegh K, Ender F, Katona G, et al. Nanoformulation of lipase from Porcine pancreas by electrospinning as a novel alternative for enzyme-based per os therapies. J MOL LIQ. 2023;389:122819.<\/p>\n<p style=\"text-align: center\"><strong>2022<\/strong><\/p>\n<p>Kazsoki A, Palcs\u00f3 B, Alp\u00e1r A, Snoeck R, Andrei G, Zelk\u00f3 R. Formulation of acyclovir (core)-dexpanthenol (sheath) nanofibrous patches for the treatment of herpes labialis. International Journal of Pharmaceutics. 2022;611:121354.<\/p>\n<p>N\u00e9meth K, Kazsoki A, Visnovitz T, Pinke B, M\u00e9sz\u00e1ros L, Buz\u00e1s EI, Zelk\u00f3 R. Nanofiber formation as a promising technology for preservation and easy storage of extracellular vesicles. SCI REP. 2022;12(1):22012.<\/p>\n<p>Palcs\u00f3 B, Kazsoki A, Herczegh A, Ghid\u00e1n \u00c1, Pinke B, M\u00e9sz\u00e1ros L, Zelk\u00f3 R. Formulation of Chlorine-Dioxide-Releasing Nanofibers for Disinfection in Humid and CO2-Rich Environment. NANOMATERIALS-BASEL. 2022;12(9):1481.<\/p>\n<p style=\"text-align: center\"><strong>2021<\/strong><\/p>\n<p>T\u00f3th GD, Kazsoki A, Gyarmati B, Szil\u00e1gyi A, Vasv\u00e1ri G, Katona G, et al. Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies. Pharmaceutics. 2021;13(7):972.<\/p>\n<p style=\"text-align: center\"><strong>2020<\/strong><\/p>\n<p>Kazsoki A, Farkas A, Balogh-Weiser D, Mancuso E, Sharma PK, Lamprou DA, Zelk\u00f3 R. Novel combination of non-invasive morphological and solid-state characterisation of drug-loaded core-shell electrospun fibres. International Journal of Pharmaceutics. 2020;587:119706.<\/p>\n<p>Kov\u00e1cs A, Kazsoki A, D\u00e9muth B, Szir\u00e1nyi B, Madar\u00e1sz J, S\u00fcvegh K, Zelk\u00f3 R. Influence of Aqueous Solubility-Enhancing Excipients on the Microstructural Characteristics of Furosemide-Loaded Electrospun Nanofibers. Pharmaceutics. 2020;12(4):385.<\/p>\n<p>Sipos E, Csat\u00e1ri T, Kazsoki A, Gergely A, Bitay E, Szab\u00f3 Z-I, Zelk\u00f3 R. Preparation and Characterization of Fenofibrate-Loaded PVP Electrospun Microfibrous Sheets. Pharmaceutics [Internet]. 2020; 12(7).<\/p>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n\n<\/div><h2 class=\"tabtitle\">PHD hallgat\u00f3k<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>PhD Hallgat\u00f3k 2024\/2025 I. f\u00e9l\u00e9v<\/strong><\/p>\n<table width=\"576\">\n<tbody>\n<tr>\n<td width=\"179\">\n<p><strong>Hallgat\u00f3 neve<\/strong><\/p>\n<\/td>\n<td width=\"132\">\n<p><strong>K\u00e9pz\u00e9s t\u00edpusa<\/strong><\/p>\n<\/td>\n<td width=\"265\">\n<p><strong>T\u00e9mavezet\u0151 neve<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Dr. Artner Anna<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na, Dr. Hank\u00f3 Bal\u00e1zs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Benk\u0151 Be\u00e1ta M\u00e1ria<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Sebe Istv\u00e1n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Dr. Budai Kinga Anna<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Hank\u00f3 Bal\u00e1zs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Dr. Horv\u00e1th Istv\u00e1n L\u00e1szl\u00f3<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Csupor Dezs\u0151<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Dr. K\u00fcrt\u00f6si Bal\u00e1zs<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Siefert Jan<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6nk\u00f6lts\u00e9ges<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. M\u00e9sz\u00e1ros \u00c1gnes<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Zimmermann Niklas<\/p>\n<\/td>\n<td width=\"132\">\n<p>\u00f6nk\u00f6lts\u00e9ges<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. M\u00e9sz\u00e1ros \u00c1gnes<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"179\">\n<p>Houssam Abboud<\/p>\n<\/td>\n<td width=\"132\">\n<p>SH \u00f6szt\u00f6nd\u00edjas<\/p>\n<\/td>\n<td width=\"265\">\n<p>Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n\n<\/div><h2 class=\"tabtitle\">TDK hallgat\u00f3k<\/h2>\n<div class=\"tabcontent\">\n\n<p><strong>TDK hallgat\u00f3k 2024\/2025 I. f\u00e9l\u00e9v<\/strong><\/p>\n<table width=\"612\">\n<tbody>\n<tr>\n<td width=\"136\">\n<p><strong>N\u00e9v<\/strong><\/p>\n<\/td>\n<td width=\"78\">\n<p><strong>\u00c9vfolyam<\/strong><\/p>\n<\/td>\n<td width=\"136\">\n<p><strong>T\u00e9mavezet\u0151<\/strong><\/p>\n<\/td>\n<td width=\"263\">\n<p><strong>T\u00e9ma<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"136\">\n<p>Farkas Eszter<\/p>\n<\/td>\n<td width=\"78\">\n<p>IV<\/p>\n<\/td>\n<td width=\"136\">\n<p>Dr. Nochta-Kazsoki Adrienn Katalin<\/p>\n<\/td>\n<td width=\"263\">\n<p>Nanosz\u00e1las hat\u00f3anyag hordoz\u00f3 rendszerek fejleszt\u00e9se \u00e9g\u00e9si s\u00e9r\u00fcl\u00e9sek kezel\u00e9s\u00e9re<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"136\">\n<p>K\u0151v\u00e1ri Gy\u00f6rgy<\/p>\n<\/td>\n<td width=\"78\">\n<p>III<\/p>\n<\/td>\n<td width=\"136\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"263\">\n<p>A mesters\u00e9ges intelligencia szerepe a betegek ter\u00e1pi\u00e1s adherenci\u00e1j\u00e1nak n\u00f6vel\u00e9s\u00e9ben<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"136\">\n<p>Perlaki Ali Barna<\/p>\n<\/td>\n<td width=\"78\">\n<p>III<\/p>\n<\/td>\n<td width=\"136\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"263\">\n<p>A mesters\u00e9ges intelligencia alkalmaz\u00e1sa a gy\u00f3gyszerel\u00e9s biztons\u00e1g\u00e1nak n\u00f6vel\u00e9s\u00e9re<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"136\">\n<p>Nagy Imre Rich\u00e1rd<\/p>\n<\/td>\n<td width=\"78\">\n<p>II<\/p>\n<\/td>\n<td width=\"136\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"263\">\n<p>A mesters\u00e9ges intelligencia alkalmaz\u00e1sa a szem\u00e9lyre szabott gy\u00f3gyszerel\u00e9sben<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"136\">\n<p>Pegah Poursafar<\/p>\n<\/td>\n<td width=\"78\">\n<p>IV<\/p>\n<\/td>\n<td width=\"136\">\n<p>Dr. Zelk\u00f3 Rom\u00e1na<\/p>\n<\/td>\n<td width=\"263\">\n<p>Polymers and Chlorine Dioxide: Analysis of Structural Changes in Materials<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[Friss\u00edtve: 2025.02.04.]<\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Int\u00e9zet\u00fcnk n\u00e9gy kutat\u00f3csoportban v\u00e9gzi tev\u00e9kenys\u00e9g\u00e9t, amelyek a gy\u00f3gyszertechnol\u00f3gia, a betegell\u00e1t\u00e1s, az eg\u00e9szs\u00e9gtudom\u00e1ny \u00e9s a nanotechnol\u00f3gia ter\u00fclet\u00e9re \u00f6sszpontos\u00edtanak. A kutat\u00e1sok c\u00e9lja a modern gy\u00f3gyszer\u00e9szet fejl\u0151d\u00e9s\u00e9nek el\u0151seg\u00edt\u00e9se, a betegek ter\u00e1pi\u00e1s lehet\u0151s\u00e9geinek jav\u00edt\u00e1sa, valamint betegk\u00f6zpont\u00fa, innovat\u00edv gy\u00f3gyszerform\u00e1k fejleszt\u00e9se. Gy\u00f3gyszer\u00e9szi gondoz\u00e1s, klinikai gy\u00f3gyszer\u00e9szet kutat\u00f3csoport A csoport f\u0151 kutat\u00e1si ter\u00fcletei k\u00f6z\u00e9 tartozik a kr\u00f3nikus betegek gy\u00f3gyszeres ter\u00e1pi\u00e1j\u00e1nak elemz\u00e9se, a gy\u00f3gyszerel\u00e9si &hellip;<\/p>\n","protected":false},"author":113,"featured_media":0,"parent":0,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"template-fullwidth.php","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-9","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/pages\/9","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/users\/113"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/comments?post=9"}],"version-history":[{"count":12,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/pages\/9\/revisions"}],"predecessor-version":[{"id":10876,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/pages\/9\/revisions\/10876"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/media?parent=9"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/categories?post=9"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/gyogyszertar\/wp-json\/wp\/v2\/tags?post=9"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}